Ligand validation:4AKN

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4AKN_EDO_A_1187	32%	91%	0.208	0.88	0.48	0.09	-	-	2	0	100%	1
5HEL_EDO_A_201	97%	92%	0.056	0.971	0.33	0.21	-	-	2	0	100%	1
5HEM_EDO_A_205	95%	91%	0.073	0.978	0.32	0.26	-	-	0	0	100%	1
7USI_EDO_E_210	89%	53%	0.106	0.985	0.61	1.18	-	-	1	0	100%	1
5HEN_EDO_C_201	86%	73%	0.084	0.951	0.36	0.66	-	-	0	0	100%	1
6DDI_EDO_A_304	79%	75%	0.109	0.956	0.25	0.71	-	-	0	0	100%	1
2G8S_EDO_A_3016	100%	84%	0.02	0.992	0.42	0.35	-	-	0	0	100%	0.7
3DPJ_EDO_B_195	100%	82%	0.022	0.994	0.47	0.34	-	-	1	0	100%	1
4EYG_EDO_A_402	100%	81%	0.024	0.995	0.44	0.39	-	-	0	0	100%	1
4NMU_EDO_D_206	100%	92%	0.025	0.997	0.38	0.14	-	-	0	0	100%	1
4Q6J_EDO_A_302	100%	82%	0.013	0.999	0.37	0.42	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.